Ticker League

West Pharmaceutical Services (WST) Profit Bridge

See what drove West Pharmaceutical Services's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

Revenue YoY

+11.22%

Operating Income YoY

+11.38%

Net Income YoY

+16.20%

Net Margin Δ

+77 bps

Net income bridge for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: $75.50M+16.20%

Profit bridge breakdown for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income$467.20M
  • Revenue$324.80M
  • Cost of Revenue−$161.40M
  • Operating Expenses−$95.40M
  • Other Income / Expense$31.10M
  • Income Tax−$27.00M
  • Other Items$3.40M
  • Net Income$542.70M
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology